Trials / Completed
CompletedNCT00916864
Biomarker for Rapid Diagnosis of Hemispheric Stroke
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Johann Wolfgang Goethe University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to estimate the diagnostic accuracy of a combined biomarker test (including NMDA-Receptor fragments \[NR2-peptide\] and Glial fibrillary acidic protein) used to differentiate between cerebral ischemia and intracerebral hemorrhage in patients with acute hemispheric stroke.
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2011-06-01
- Completion
- 2011-06-01
- First posted
- 2009-06-10
- Last updated
- 2011-06-23
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00916864. Inclusion in this directory is not an endorsement.